FDA OKs First Oral ADT for Prostate Cancer

(MedPage Today) -- WASHINGTON--The FDA on Friday approved relugolix (Orgovyx), an oral androgen deprivation therapy (ADT) for men with advanced prostate cancer.
"Today's approval marks the first oral drug in this class and it may eliminate...